Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Arch Pathol Lab Med. 2010 Jan;134(1):41-8. doi: 10.5858/134.1.41.
Recent advances in human imaging technologies reawakened interest in lung cancer screening. Although historic and current preliminary and noncontrolled studies have not shown a decrease in lung cancer mortality in screened populations, many explanations have been proffered while the lung cancer community awaits the results of several large controlled population studies.
To critically review the current model of adenocarcinoma development against the background of lung cancer screening results combined with observational pathologic and radiographic studies.
Published articles pertaining to lung cancer screening, lung adenocarcinoma pathology, and radiology accessible through PubMed form the basis for this review.
The current adenocarcinogenesis model is probably valid for many but not all lung adenocarcinomas. Screening data combined with radiographic and pathologic studies suggest that not all lung adenocarcinomas are clinically aggressive, and it is uncertain whether all aggressive adenocarcinomas arise from identified precursors.
近年来,人类影像学技术的进步重新唤起了对肺癌筛查的兴趣。尽管历史和当前的初步和非对照研究并未显示筛查人群的肺癌死亡率降低,但在等待几项大型对照人群研究结果的同时,肺癌领域提出了许多解释。
批判性地回顾腺癌发展的当前模型,该模型以肺癌筛查结果为背景,结合观察性病理和影像学研究。
通过 PubMed 可获得与肺癌筛查、肺腺癌病理学和放射学相关的已发表文章,为本次综述提供了依据。
当前的腺癌发生模型可能适用于许多但不是所有的肺腺癌。筛查数据结合影像学和病理学研究表明,并非所有肺腺癌都具有临床侵袭性,也不确定所有侵袭性腺癌是否都源自已识别的前体。